NCT00067769

Brief Summary

Encopresis, also known as fecal incontinence, is the voluntary or involuntary passage of stools causing soiling of clothes by a child over 4 years of age. The purpose of this study is to evaluate an Internet intervention for the treatment of encopresis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 28, 2003

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2003

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
Last Updated

December 7, 2015

Status Verified

June 1, 2014

Enrollment Period

3.8 years

First QC Date

August 27, 2003

Last Update Submit

December 4, 2015

Conditions

Keywords

EncopresisInternetWebTreatmentIntervention

Outcome Measures

Primary Outcomes (2)

  • Fecal accident outcomes with online diary data

    Number of accidents per 2 week period

    Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  • Success and cure rates

    Success rate as defined by having zero or one fecal accident over a two week period. Cure rate as defined by having zero accidents over the previous two weeks.

    Post (4-6 weeks) and one year Post after the intervention period (4-6 weeks)

Secondary Outcomes (4)

  • Fecal accident outcomes with retrospective data

    Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  • Parent knowledge of encopresis

    Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  • Virginia Encopresis Constipation Apperception Test (VECAT)

    Pre, Post (4-6 weeks), and one year Post after the intervention period (4-6 weeks)

  • Encopresis Cost Analysis

    Pre and Post (4-6 weeks)

Other Outcomes (2)

  • Usage patterns of the Internet intervention

    Post (4-6 weeks)

  • Internet Intervention Utility Measure of Satisfaction

    Post (4-6 weeks)

Study Arms (2)

TAU

ACTIVE COMPARATOR

Patients received treatment as usual (TAU) as defined as continued clinical care.

Behavioral: treatment as usual

TAU+UCanPoopToo

EXPERIMENTAL

Patients received treatment as usual (TAU) plus the Internet intervention (UCanPoopToo.)

Behavioral: Internet-based intervention UCanPoopToo

Interventions

Internet-based intervention to administer Enhanced Toilet Training (ETT).

TAU+UCanPoopToo

Routine clinical care.

TAU

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Child seen by pediatrician, family physician, or psychologist for the treatment of encopresis
  • Access to the Internet, either through a family computer or a community computer

You may not qualify if:

  • Diagnosis of either mental retardation (IQ \< 85) or
  • A primary illness responsible for fecal soiling (e.g., spina bifida)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia Health System

Charlottesville, Virginia, 22902, United States

Location

Related Publications (8)

  • Ritterband LM, Cox DJ, Walker LS, Kovatchev B, McKnight L, Patel K, Borowitz S, Sutphen J. An Internet intervention as adjunctive therapy for pediatric encopresis. J Consult Clin Psychol. 2003 Oct;71(5):910-7. doi: 10.1037/0022-006X.71.5.910.

    PMID: 14516239BACKGROUND
  • Cox DJ, Morris JB Jr, Borowitz SM, Sutphen JL. Psychological differences between children with and without chronic encopresis. J Pediatr Psychol. 2002 Oct-Nov;27(7):585-91. doi: 10.1093/jpepsy/27.7.585.

    PMID: 12228330BACKGROUND
  • Borowitz SM, Cox DJ, Sutphen JL, Kovatchev B. Treatment of childhood encopresis: a randomized trial comparing three treatment protocols. J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):378-84. doi: 10.1097/00005176-200204000-00012.

    PMID: 11930093BACKGROUND
  • Brooks RC, Copen RM, Cox DJ, Morris J, Borowitz S, Sutphen J. Review of the treatment literature for encopresis, functional constipation, and stool-toileting refusal. Ann Behav Med. 2000 Summer;22(3):260-7. doi: 10.1007/BF02895121.

    PMID: 11211851BACKGROUND
  • Borowitz SM, Cox DJ, Sutphen JL. Differences in toileting habits between children with chronic encopresis, asymptomatic siblings, and asymptomatic nonsiblings. J Dev Behav Pediatr. 1999 Jun;20(3):145-9. doi: 10.1097/00004703-199906000-00002.

    PMID: 10393070BACKGROUND
  • Cox DJ, Sutphen J, Borowitz S, Kovatchev B, Ling W. Contribution of behavior therapy and biofeedback to laxative therapy in the treatment of pediatric encopresis. Ann Behav Med. 1998 Spring;20(2):70-6. doi: 10.1007/BF02884451.

    PMID: 9989311BACKGROUND
  • Cox DJ, Sutphen J, Ling W, Quillian W, Borowitz S. Additive benefits of laxative, toilet training, and biofeedback therapies in the treatment of pediatric encopresis. J Pediatr Psychol. 1996 Oct;21(5):659-70. doi: 10.1093/jpepsy/21.5.659.

    PMID: 8936895BACKGROUND
  • Ling W, Cox DJ, Sutphen J, Borowitz S. Psychological factors in encopresis: comparison of patients to nonsymptomatic siblings. Clin Pediatr (Phila). 1996 Aug;35(8):427. doi: 10.1177/000992289603500814. No abstract available.

    PMID: 8862907BACKGROUND

MeSH Terms

Conditions

Encopresis

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Study Officials

  • Daniel J Cox, PhD

    University of Virginia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Psychiatry and NB Sciences

Study Record Dates

First Submitted

August 27, 2003

First Posted

August 28, 2003

Study Start

October 1, 2003

Primary Completion

July 1, 2007

Study Completion

July 1, 2007

Last Updated

December 7, 2015

Record last verified: 2014-06

Locations